Comparison of IV Sucrose and IV Carboxymaltose in Patients with Anemia in Pregnancy
DOI:
https://doi.org/10.70749/ijbr.v3i4.2499Keywords:
Ferric Carboxymaltose, Iron Sucrose, Iron Deficiency Anemia in Pregnancy, Hemoglobin ImprovementAbstract
Background: Pregnancy-associated iron deficiency anemia is a major health problem for its role in causing maternal morbidity and undesirable perinatal outcomes. Standard therapy with intravenous iron sucrose consists of multiple frequent small infusions, with ferric carboxymaltose accepting larger single doses at shorter intervals. There remains sparse direct evidence for a comparison between their effectiveness in pregnancy. Objective: To compare the effectiveness of intravenous ferric carboxymaltose and intravenous iron sucrose in pregnant women with moderate to severe iron deficiency anemia. Study Design: Randomized controlled trial. Place and Duration of Study: This trial was conducted from June 2024 to November 2024 in the Department of Obstetrics and Gynecology, SKBZ Combined Military Hospital, Muzaffarabad. Methodology: Sixty pregnant women between 16 and 24 weeks of gestation, with hemoglobin levels ranging from 7 to 10 grams per deciliter, were randomized into two equal groups. One group received ferric carboxymaltose in single doses up to 1000 milligrams, while the other group received iron sucrose in divided doses not exceeding 600 milligrams per week. Hemoglobin and red cell indices were recorded at baseline and during follow-up at 3, 6, and 12 weeks. Results: Baseline demographic and clinical features were comparable between the two groups. After 12 weeks, mean hemoglobin significantly increased in the ferric carboxymaltose group (113.45±4.95 g/L) compared to the iron sucrose group (106.29±4.87 g/L). The average rise from baseline was greater with ferric carboxymaltose (29.32±3.23 g/L) than with iron sucrose (22.25±1.75 g/L, p<0.001). Stratified analysis confirmed superior outcomes with ferric carboxymaltose across all subgroups, including maternal age, parity, socioeconomic status, and place of residence. No serious adverse reactions were observed. Conclusion: Ferric carboxymaltose is more effective than iron sucrose in correcting antenatal iron deficiency anemia, producing a greater and faster rise in hemoglobin with fewer infusions.
Downloads
References
1. Srimathi, G., Revathy, R., Bagepally, B. S., & Joshi, B. (2024). Clinical effectiveness of ferric carboxymaltose (IV) versus iron sucrose (IV) in treatment of iron deficiency anaemia in pregnancy: A systematic review and meta-analysis. Indian Journal of Medical Research, 159(1), 62-70.
https://doi.org/10.4103/ijmr.ijmr_246_23
2. Benson, A. E., Shatzel, J. J., Ryan, K. S., Hedges, M. A., Martens, K., Aslan, J. E., & Lo, J. O. (2022). The incidence, complications, and treatment of iron deficiency in pregnancy. European Journal of Haematology, 109(6), 633-642.
https://doi.org/10.1111/ejh.13870
3. Pandey, A. K., Gautam, D., Tolani, H., & Neogi, S. B. (2024). Clinical outcome post treatment of anemia in pregnancy with intravenous versus oral iron therapy: A systematic review and meta-analysis. Scientific Reports, 14(1).
https://doi.org/10.1038/s41598-023-50234-w
4. Patel, G., Thanvi, I., Seervi, R., & Jakhar, R. (2025). Evaluation of therapeutic response and tolerability to intravenous iron sucrose and ferric carboxymaltose among pregnant women with iron deficiency anemia: A 6 year experience in a tertiary care center. Medicine International, 5(4), 1-8.
https://doi.org/10.3892/mi.2025.233
5. Society for Maternal-Fetal Medicine. Large study finds IV iron treatment during pregnancy safe and effective for anemia. SMFM News. 2025.
6. Pasricha, S., Moya, E., Ataíde, R., Mzembe, G., Harding, R., Mwangi, M. N., Zinenani, T., Prang, K., Kaunda, J., Mtambo, O. P., Vokhiwa, M., Mhango, G., Mamani-Mategula, E., Fielding, K., Demir, A., Von Dinklage, N., Verhoef, H., McLean, A. R., Manda-Taylor, L., … Phiri, K. S. (2025). Ferric carboxymaltose for anemia in late pregnancy: A randomized controlled trial. Nature Medicine, 31(1), 197-206.
https://doi.org/10.1038/s41591-024-03385-w
7. Rathod, S., Samal, S., Mahapatra, P., & Samal, S. (2015). Ferric carboxymaltose: A revolution in the treatment of postpartum anemia in Indian women. International Journal of Applied and Basic Medical Research, 5(1), 25.
https://doi.org/10.4103/2229-516x.149230
8. Qayyum, J., Farhan, S. Q., Qureshi, Q. U., Jamali, A. G., Fatima, A., Imtiaz, B., Alharbi, N. M., Partab, F., Shweta, F., & Kumar, V. (2025). Comparing the treatment outcomes of oral and injectable iron therapies for anemia in pregnancy: A meta-analysis. Cureus.
https://doi.org/10.7759/cureus.78326
9. Aslan, S., Doğan, S., Sarıaydın, M., Vural, A., Kuloglu, E., & Muhtaroğlu, A. (2025). Comparative impact of intravenous iron sucrose and ferric Carboxymaltose on Hypophosphatemia and anemia parameters in iron deficiency anemia: A retrospective study. Therapeutics and Clinical Risk Management, 21, 987-993.
https://doi.org/10.2147/tcrm.s529064
10. Bedan, M., & Lottrup, C. (2025). Intravenous iron therapy versus blood transfusion for iron deficiency anemia: A systematic review. Transfusion Medicine Reviews, 39(3), 150905.
https://doi.org/10.1016/j.tmrv.2025.150905
11. Nicholson, L., Axon, E., Daru, J., & Rogozińska, E. (2024). Effect and safety of intravenous iron compared to oral iron for treatment of iron deficiency anaemia in pregnancy. Cochrane Database of Systematic Reviews, 2025(1).
https://doi.org/10.1002/14651858.cd016136
12. Arzoo, K., Jan, S., Anwar, R., Ali, R., Masood, A., & Rehman, M. A. (2025). Efficacy of intravenous ferric Carboxymaltose versus iron sucrose in the treatment of iron deficiency anemia of pregnancy. Pakistan Journal of Health Sciences, 131-135.
https://doi.org/10.54393/pjhs.v6i2.2328
13. Jose, A., Mahey, R., Sharma, J. B., Bhatla, N., Saxena, R., Kalaivani, M., & Kriplani, A. (2019). Comparison of ferric Carboxymaltose and iron sucrose complex for treatment of iron deficiency anemia in pregnancy- randomised controlled trial. BMC Pregnancy and Childbirth, 19(1).
https://doi.org/10.1186/s12884-019-2200-3
14. Lyseng-Williamson, K. A., & Keating, G. M. (2009). Ferric Carboxymaltose. Drugs, 69(6), 739-756.
https://doi.org/10.2165/00003495-200969060-00007
15. Jamal, H., Zafar, H., Naz, M., Fatima, U., & Fatima, A. (2021). Comparison of ferric carboxymaltose versus iron sucrose for treatment of iron deficiency anemia in pregnancy. The Professional Medical Journal, 28(04), 481-484.
https://doi.org/10.29309/tpmj/2021.28.03.5935
16. Saleem, K., Yaseen, N., Saleem, H., Noor, L., Arif, M., & Nawaz, M. M. (2025). Comparison of ferric Carboxymaltose versus iron sucrose for treatment of iron deficiency anaemia in pregnant women. Journal of The Society of Obstetricians and Gynaecologists of Pakistan, 15(3), 155-160.
https://doi.org/10.71104/jsogp.v15i3.896
17. Sharma, A., Pehal, Y., Saxena, N., & Agrawal, S. (2025). A comparative study to evaluate the safety and efficacy of intravenous iron sucrose versus ferric Carboxymaltose in the treatment of iron deficiency anemia in pregnancy. Journal of Obstetrics, Gynecology and Cancer Research, 10(3), 239-247.
https://doi.org/10.30699/jogcr.10.3.239
18. Arzoo, K., Jan, S., Anwar, R., Ali, R., Masood, A., & Rehman, M. A. (2025). Efficacy of intravenous ferric Carboxymaltose versus iron sucrose in the treatment of iron deficiency anemia of pregnancy. Pakistan Journal of Health Sciences, 131-135.
https://doi.org/10.54393/pjhs.v6i2.2328
19. Papaniya, T. D., Parmar, M. T., & Solanki, H. M. (2023). Comparison of ferric carboxymaltose and iron sucrose for treatment of iron deficiency anemia in pregnancy at tertiary care centre, western India. International Journal of Reproduction, Contraception, Obstetrics and Gynecology, 12(6), 1844-1848.
https://doi.org/10.18203/2320-1770.ijrcog20231566
20. Chaturvedi, J., K, R., Bahadur, A., Heda, A., & Mundhra, R. (2024). Comparative analysis of ferric carboxymaltose and iron sucrose in treating iron deficiency anemia in perimenopausal women with heavy menstrual bleeding: A randomized controlled trial. Obstetrics & Gynecology Science, 67(6), 565-573.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Indus Journal of Bioscience Research
This work is licensed under a Creative Commons Attribution 4.0 International License.
